Henrik Sundin is a lawyer by training and has extensive experience from the financial sector. He has held CEO positions and served as a board member of several companies in this sector. Henrik Sundin is also an active investor in a number of companies. Henrik Sundin brings expertise in areas of business development, strategy and capital market issues to the company. Henrik has been an investor in Hamlet BioPharma since the company’s IPO.